Olive J. Sturtevant MHP, MT(ASCP)SBB, SLS, CQA(ASQ)

Olive Sturtevant and her team provide leadership and regulatory direction for multiple cellular therapy programs at Dana-Farber, Brigham and Women's Hospital, and Boston Children's Hospital. Olive acts as both a resource and consultant on matters of clinical laboratory compliance; GMP and GTP cell and tissue manufacturing; and overall quality and regulatory topics that range from cellular therapy adverse events and quality improvement processes and metrics to regulatory compliance for early-phase novel cell therapy manufacturing.